CAJ | 학술논문

目的：观察雷贝拉唑+克拉霉素+左氧氟沙星三联疗法治疗幽门螺杆菌消化道溃疡的疗效。方法：60例幽门螺杆菌阳性消化道溃疡患者随机平分为两组，两组患者都采用三联一周疗法，治疗组为雷贝拉唑+克拉霉素+左氧氟沙星治疗，对照组为奥美拉唑+阿莫西林+甲硝唑治疗。结果：经过治疗，治疗组30例96.7%的总有效率明显高于对照组70.0%的总有效率（P＜0.05）；治疗组90.0%的HP根除率明显高于对照组66.7%的HP根除率（P＜0.05）。结论：雷贝拉唑+克拉霉素+左氧氟沙星三联疗法治疗幽门螺杆菌消化道溃疡能提高疗效，提高HP根除率，值得推广应用。
목적：관찰뢰패랍서+극랍매소+좌양불사성삼련요법치료유문라간균소화도궤양적료효。방법：60례유문라간균양성소화도궤양환자수궤평분위량조，량조환자도채용삼련일주요법，치료조위뢰패랍서+극랍매소+좌양불사성치료，대조조위오미랍서+아막서림+갑초서치료。결과：경과치료，치료조30례96.7%적총유효솔명현고우대조조70.0%적총유효솔（P＜0.05）；치료조90.0%적HP근제솔명현고우대조조66.7%적HP근제솔（P＜0.05）。결론：뢰패랍서+극랍매소+좌양불사성삼련요법치료유문라간균소화도궤양능제고료효，제고HP근제솔，치득추엄응용。
Objective:To investigate rabeprazole levofloxacin clarithromycin triple therapies for Helicobacter pylori peptic ulcer effect. Methods: 60 cases of H. pylori-positive peptic ulcer patients randomly divided into two groups, both groups have adopted one week triple therapy treatment group clarithromycin rabeprazole levofloxacin therapy, the control group was omeprazole + amoxicillin amoxicillin + metronidazole therapy. Results: After treatment, the treatment group of 30 patients was 96.7% of the total efficiency significantly different than the control group and 70.0% of the total efficiency (P<0.05); treatment group 90.0% of HP eradication rate of 66.7% was significantly higher HP eradication rate (P<0.05). Conclusion: rabeprazole levofloxacin clarithromycin triple therapies for Helicobacter pylori peptic ulcer therapy can improve, enhance HP eradication rate, should be widely applied.